<!DOCTYPE html>
<html>

<head>

<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">
<title>Clinical Practice - Trauma</title>


<style type="text/css">
body {
  font-family: Helvetica, arial, sans-serif;
  font-size: 14px;
  line-height: 1.6;
  padding-top: 10px;
  padding-bottom: 10px;
  background-color: white;
  padding: 30px; }

body > *:first-child {
  margin-top: 0 !important; }
body > *:last-child {
  margin-bottom: 0 !important; }

a {
  color: #4183C4; }
a.absent {
  color: #cc0000; }
a.anchor {
  display: block;
  padding-left: 30px;
  margin-left: -30px;
  cursor: pointer;
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0; }

h1, h2, h3, h4, h5, h6 {
  margin: 20px 0 10px;
  padding: 0;
  font-weight: bold;
  -webkit-font-smoothing: antialiased;
  cursor: text;
  position: relative; }

h1:hover a.anchor, h2:hover a.anchor, h3:hover a.anchor, h4:hover a.anchor, h5:hover a.anchor, h6:hover a.anchor {
  background: url(data:image/png;base64,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) no-repeat 10px center;
  text-decoration: none; }

h1 tt, h1 code {
  font-size: inherit; }

h2 tt, h2 code {
  font-size: inherit; }

h3 tt, h3 code {
  font-size: inherit; }

h4 tt, h4 code {
  font-size: inherit; }

h5 tt, h5 code {
  font-size: inherit; }

h6 tt, h6 code {
  font-size: inherit; }

h1 {
  font-size: 28px;
  color: black; }

h2 {
  font-size: 24px;
  border-bottom: 1px solid #cccccc;
  color: black; }

h3 {
  font-size: 18px; }

h4 {
  font-size: 16px; }

h5 {
  font-size: 14px; }

h6 {
  color: #777777;
  font-size: 14px; }

p, blockquote, ul, ol, dl, li, table, pre {
  margin: 15px 0; }

hr {
  background: transparent url(data:image/png;base64,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) repeat-x 0 0;
  border: 0 none;
  color: #cccccc;
  height: 4px;
  padding: 0;
}

body > h2:first-child {
  margin-top: 0;
  padding-top: 0; }
body > h1:first-child {
  margin-top: 0;
  padding-top: 0; }
  body > h1:first-child + h2 {
    margin-top: 0;
    padding-top: 0; }
body > h3:first-child, body > h4:first-child, body > h5:first-child, body > h6:first-child {
  margin-top: 0;
  padding-top: 0; }

a:first-child h1, a:first-child h2, a:first-child h3, a:first-child h4, a:first-child h5, a:first-child h6 {
  margin-top: 0;
  padding-top: 0; }

h1 p, h2 p, h3 p, h4 p, h5 p, h6 p {
  margin-top: 0; }

li p.first {
  display: inline-block; }
li {
  margin: 0; }
ul, ol {
  padding-left: 30px; }

ul :first-child, ol :first-child {
  margin-top: 0; }

dl {
  padding: 0; }
  dl dt {
    font-size: 14px;
    font-weight: bold;
    font-style: italic;
    padding: 0;
    margin: 15px 0 5px; }
    dl dt:first-child {
      padding: 0; }
    dl dt > :first-child {
      margin-top: 0; }
    dl dt > :last-child {
      margin-bottom: 0; }
  dl dd {
    margin: 0 0 15px;
    padding: 0 15px; }
    dl dd > :first-child {
      margin-top: 0; }
    dl dd > :last-child {
      margin-bottom: 0; }

blockquote {
  border-left: 4px solid #dddddd;
  padding: 0 15px;
  color: #777777; }
  blockquote > :first-child {
    margin-top: 0; }
  blockquote > :last-child {
    margin-bottom: 0; }

table {
  padding: 0;border-collapse: collapse; }
  table tr {
    border-top: 1px solid #cccccc;
    background-color: white;
    margin: 0;
    padding: 0; }
    table tr:nth-child(2n) {
      background-color: #f8f8f8; }
    table tr th {
      font-weight: bold;
      border: 1px solid #cccccc;
      margin: 0;
      padding: 6px 13px; }
    table tr td {
      border: 1px solid #cccccc;
      margin: 0;
      padding: 6px 13px; }
    table tr th :first-child, table tr td :first-child {
      margin-top: 0; }
    table tr th :last-child, table tr td :last-child {
      margin-bottom: 0; }

img {
  max-width: 100%; }

span.frame {
  display: block;
  overflow: hidden; }
  span.frame > span {
    border: 1px solid #dddddd;
    display: block;
    float: left;
    overflow: hidden;
    margin: 13px 0 0;
    padding: 7px;
    width: auto; }
  span.frame span img {
    display: block;
    float: left; }
  span.frame span span {
    clear: both;
    color: #333333;
    display: block;
    padding: 5px 0 0; }
span.align-center {
  display: block;
  overflow: hidden;
  clear: both; }
  span.align-center > span {
    display: block;
    overflow: hidden;
    margin: 13px auto 0;
    text-align: center; }
  span.align-center span img {
    margin: 0 auto;
    text-align: center; }
span.align-right {
  display: block;
  overflow: hidden;
  clear: both; }
  span.align-right > span {
    display: block;
    overflow: hidden;
    margin: 13px 0 0;
    text-align: right; }
  span.align-right span img {
    margin: 0;
    text-align: right; }
span.float-left {
  display: block;
  margin-right: 13px;
  overflow: hidden;
  float: left; }
  span.float-left span {
    margin: 13px 0 0; }
span.float-right {
  display: block;
  margin-left: 13px;
  overflow: hidden;
  float: right; }
  span.float-right > span {
    display: block;
    overflow: hidden;
    margin: 13px auto 0;
    text-align: right; }

code, tt {
  margin: 0 2px;
  padding: 0 5px;
  white-space: nowrap;
  border: 1px solid #eaeaea;
  background-color: #f8f8f8;
  border-radius: 3px; }

pre code {
  margin: 0;
  padding: 0;
  white-space: pre;
  border: none;
  background: transparent; }

.highlight pre {
  background-color: #f8f8f8;
  border: 1px solid #cccccc;
  font-size: 13px;
  line-height: 19px;
  overflow: auto;
  padding: 6px 10px;
  border-radius: 3px; }

pre {
  background-color: #f8f8f8;
  border: 1px solid #cccccc;
  font-size: 13px;
  line-height: 19px;
  overflow: auto;
  padding: 6px 10px;
  border-radius: 3px; }
  pre code, pre tt {
    background-color: transparent;
    border: none; }

sup {
    font-size: 0.83em;
    vertical-align: super;
    line-height: 0;
}

kbd {
  display: inline-block;
  padding: 3px 5px;
  font-size: 11px;
  line-height: 10px;
  color: #555;
  vertical-align: middle;
  background-color: #fcfcfc;
  border: solid 1px #ccc;
  border-bottom-color: #bbb;
  border-radius: 3px;
  box-shadow: inset 0 -1px 0 #bbb
}

* {
	-webkit-print-color-adjust: exact;
}
@media screen and (min-width: 914px) {
    body {
        width: 854px;
        margin:0 auto;
    }
}
@media print {
	table, pre {
		page-break-inside: avoid;
	}
	pre {
		word-wrap: break-word;
	}
}
</style>


</head>

<body>

<h2 id="toc_0">Ornge Clinical Practice Guideline: Trauma</h2>

<p><i>Please refer to the Drug Monographs and References document for references listed in the CPGs</i></p>

<h2>The role of Ornge within the Ontario trauma system:</h2>
<p>Organized systems of trauma care improve mortality for trauma patients<sup>1</sup>. Studies have demonstrated up to a 25% reduction in mortality for severely injured patients who received care at a trauma centre compared to patients treated at a non–trauma centre<sup>2-4</sup>. This, however, presents a unique challenge to much of Ontario. For example, 40% of the population lives more than a 60-minute drive to a trauma centre and 15% are more than a 60-minute transport by air ambulance to a trauma centre<sup>5</sup>. Ornge is an essential link to providing timely trauma access for many patients in Ontario. Air transport from scene should be considered for trauma patients meeting appropriate physiologic and anatomic criteria, in accordance with the Field Trauma Triage Standard (FTTS) and Air Ambulance Utilization Standard (AAUS)<sup>6</sup>. A recent Ontario study also demonstrated that patients transported by helicopter to an urban trauma centre had improved survival compared to patients transported by land ambulance despite being more severely injured and requiring more interventions.</p>
<h2>Spinal motion restriction</h2>
<p>The American College of Surgeons Committee on Trauma (ACS-COT), American College of Emergency Physicians (ACEP), and the National Association of EMS Physicians (NAEMSP) have released an updated consensus statement on spinal motion restriction (SMR) in the trauma patient<sup>7</sup>. While current techniques limit or reduce undesired motion of the spine, they do not provide true spinal immobilization. For this reason, the term SMR has gained favor over “spinal immobilization,” although both terms refer to the same concept. The goal of both SMR and spinal immobilization in the trauma patient is to minimize unwanted movement of the potentially injured spine.</p>
<p>Indications for SMR following blunt trauma include:</p>
<ol>
    <li>Acutely altered level of consciousness (e.g., GCS &lt;15, evidence of intoxication)</li>
    <li>Midline neck or back pain and/or tenderness</li>
    <li>Focal neurologic signs and/or symptoms (e.g., numbness or motor weakness)</li>
    <li>Anatomic deformity of the spine</li>
    <li>Distracting circumstances or injury (e.g., long bone fracture, degloving, or crush injuries, large burns, emotional distress, communication barrier, etc.) or any similar injury that impairs the patient’s ability to contribute to a reliable examination</li>
</ol>
<p>Utilization of backboards for spinal immobilization has mostly fallen out of favour and use during transport should be judicious, so that the potential benefits outweigh the risks. If indicated, SMR can be maintained by application of a rigid cervical collage and securing the patient firmly to the stretcher and may be most appropriate for patients who must be transported for a protracted time, particularly prior to interfacility transfer<sup>7</sup>.</p>
<p>There is no role for SMR in penetrating trauma<sup>7</sup>.</p>
<h2>Airway management in trauma patients</h2>
<p>Positive pressure ventilation causes increased intrathoracic pressure and therefore decreases venous return and reduces cardiac output , resulting in further hypoperfusion and shock<sup>8</sup>. In critically ill trauma patients that are severely hypovolemic and dependent on venous return and their adrenergic response to maintain perfusion, intubation may even precipitate death<sup>8</sup>. It may be reasonable to manage with BLS interventions if they are successful at maintaining a patent airway with appropriate oxygenation and ventilation when transport times to the Lead Trauma Hospital (LTH) are relatively short (<30 min)<sup>8-12</sup>.</p>
<p>If it is determined that definitive airway management is required, attempts should be made to “resuscitate” prior to intubation through appropriate volume replacement, initiation of vasopressors, and needle thoracostomies (if indicated).</p>
<h2> Management of hemorrhagic shock</h2>
<p>Hypotensive trauma patients in hemorrhagic shock<sup>13</sup> should be treated using a damage control resuscitative approach:</p>
<ul>
    <li>Hypothermia should be prevented and treated aggressively</li>
    <li>Hemorrhage control should be secured using tourniquets for extremity injury</li>
    <li>Blood component therapy should be considered early, in a 1:1:1 or 2:1:1 ratio, if possible</li>
    <li>Crystalloids should be minimized, if blood products are available</li>
    <li>Permissive hypotension should be considered for patients suffering penetrating torso injury</li>
    <li>Target systolic blood pressure should be 90 mmHg. However, in all cases, perfusion of the brain (level of consciousness) must be maintained</li>
</ul>
<p>When additional blood component therapy is not available (i.e., plasma), attempts at balanced resuscitation should be made by use of Prothrombin Complex Concentrate (PCC) 2000 IU and Fibrinogen Concentrate 4g<sup>14</sup>.</p>
<p>Tranexamic acid (2 g over 10 minutes) should be administered to trauma patients who are believed to be bleeding, and who are tachycardic or hypotensive (HR &gt; 100, or Systolic BP &lt; 100). This should only be initiated if the patient is seen within 3 hours of the injury<sup>15</sup>.</p>
<h2>Management of traumatic brain injury</h2>
<p>In the setting of severe traumatic brain injury (GCS &lt;9), hypoxemia (SpO2 &lt;90%) and hypotension (systolic BP &lt;90 mmHg) are associated with increased mortality and should be avoided<sup>16,17</sup>. A MAP ≥80 mmHg should be maintained. Scene intubation for patients with traumatic brain injury is controversial<sup>18</sup> and there should be careful attention to mitigate hypoxia and hypotension during intubation if required (i.e., optimizing hemodynamics, reduced dose induction agents, availability of push dose pressors, and use of apneic oxygenation)</p>
<p>General measures for prevention and treatment of elevated ICP should include elevation of the head of bed to 30 degrees, optimization of venous drainage by keeping the neck in a neutral position, using appropriately sized cervical collar, and appropriate management of analgesia, sedation, and nausea<sup>19</sup>. Target PaCO2 should be maintained at 35-40 mm Hg (surrogate marker of ETCO2 should be maintained at 33-38 mmHg) and hyperventilation (ETCO2 &lt; 33 mmHg) should be avoided unless the patient shows signs of cerebral herniation. Signs of cerebral herniation include dilated and unreactive pupils, asymmetric pupils, a motor exam that identifies extensor posturing or no response, or progressive neurologic deterioration (decrease in GCS of &gt;2 points from the patient’s best score of &lt;9)<sup>20,21</sup>.</p>
<p>Hyperosmolar agents (hypertonic saline, mannitol) may be considered for patients showing signs of cerebral herniation and may improve cerebral blood flow<sup>19-23</sup>. Mannitol should NOT be used in patients with suspected hypovolemia (tachycardia and/or hypotension). Hyperventilation can be considered as a second-line therapy if there are severe signs of increased ICP (including Cushing’s triad with systolic hypertension, bradycardia, and irregular respirations) or signs of cerebral herniation despite the first-line therapies listed above. Hyperventilation should target PaCO2 32-35 (surrogate marker of ETCO2 30-35).</p>
<p>Hyperoxia (defined by a supranormal arterial O2 tension) may be associated with increased mortality in traumatic brain injury and should be avoided, maintaining SaO2 94-98%<sup>24</sup>.</p>

</body>

</html>
